Cargando…
Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein: Initial Steps
[Image: see text] Recent crystal structure data for protein–protein interactions featuring the SARS-CoV-2 spike protein will inevitably trigger a new wave of research in this area that was not possible before. This Viewpoint outlines a few of the ways that it is already happening.
Autores principales: | Whisenant, Jonathan, Burgess, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241730/ https://www.ncbi.nlm.nih.gov/pubmed/32547694 http://dx.doi.org/10.1021/acsmedchemlett.0c00233 |
Ejemplares similares
-
Inhibition of SARS-CoV-2 Spike Protein Function by Amphiphilic Block Copolymers
por: Ling, Michelle X., et al.
Publicado: (2021) -
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
por: Sternberg, Ariane, et al.
Publicado: (2020) -
Spike Glycoprotein Is Central to Coronavirus Pathogenesis-Parallel
Between m-CoV and SARS-CoV-2
por: Saadi, Fareeha, et al.
Publicado: (2021) -
Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
por: Li, Changzhi, et al.
Publicado: (2022) -
DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)